Kefeng Lu
Impact in
- Epidemiology top 5%
- Autophagy in Disease and Therapy
- Molecular Biology top 10%
- Ubiquitin and proteasome pathways
- TGF-β signaling in diseases
- Epigenetics and DNA Methylation
- Bone Metabolism and Diseases
Papers in
- Epidemiology 27
- Autophagy in Disease and Therapy 26
- Hepatitis B Virus Studies 2
-
- Ubiquitin and proteasome pathways 11
- Protein Kinase Regulation and GTPase Signaling 2
- TGF-β signaling in diseases 2
- Genomics and Chromatin Dynamics 2
- Co-authors
- Stefan Jentsch (3 shared papers)Ivan Psakhye (2 shared papers)Lingqiang Zhang (14 shared papers)Guichun Xing (13 shared papers)Huihui Li (18 shared papers)Fuchu He (11 shared papers)Yong Lin (5 shared papers)Binli Mao (2 shared papers)
- Journals
- Autophagy (4 papers)Nature Cell Biology (3 papers)Advances in experimental medicine and biology (3 papers)EMBO Reports (2 papers)Scientific Reports (2 papers)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Kefeng Lu
50 papers receiving 2.1k citations
Kefeng Lu's Hit Papers
Peers
Comparison fields: 5 of 89
- Epidemiology 524
- Molecular Biology 893
- Infectious Diseases 143
- Cancer Research 94
- Immunology 135
Countries citing papers authored by Kefeng Lu
This map shows the geographic impact of Kefeng Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kefeng Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kefeng Lu more than expected).
Fields of papers citing papers by Kefeng Lu
This network shows the impact of papers produced by Kefeng Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kefeng Lu. The network helps show where Kefeng Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Kefeng Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 306 | |
| 2 | The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes Hit paper breakdown → | 2021 | 200 |
| 3 | 2014 | 183 | |
| 4 | 2008 | 147 | |
| 5 | 2021 | 108 | |
| 6 | 2009 | 97 | |
| 7 | 2017 | 86 | |
| 8 | 2008 | 76 | |
| 9 | 2014 | 69 | |
| 10 | 2014 | 67 | |
| 11 | 2020 | 59 | |
| 12 | 2009 | 54 | |
| 13 | 2011 | 52 | |
| 14 | 2021 | 51 | |
| 15 | 2013 | 44 | |
| 16 | 2011 | 43 | |
| 17 | 2014 | 42 | |
| 18 | 2021 | 42 | |
| 19 | 2020 | 40 | |
| 20 | 2016 | 28 |
About Kefeng Lu
Kefeng Lu is a scholar working on Epidemiology, Molecular Biology, Endocrinology, Cell Biology and Neurology, having authored 51 papers that have together received 2.1k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (26 papers), Ubiquitin and proteasome pathways (11 papers), Hepatitis B Virus Studies (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), TGF-β signaling in diseases (2 papers), Genomics and Chromatin Dynamics (2 papers), Cancer-related Molecular Pathways (2 papers) and Amyotrophic Lateral Sclerosis Research (2 papers). The work is most often cited by research in Epidemiology (524 citations), Molecular Biology (893 citations), Infectious Diseases (143 citations), Cancer Research (94 citations) and Immunology (135 citations). Kefeng Lu has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Stefan Jentsch, Ivan Psakhye, Lingqiang Zhang, Guichun Xing, Huihui Li, Fuchu He, Yong Lin, Binli Mao, Zhenyu Zhao and Fabian den Brave. Their work appears in journals such as Autophagy, Nature Cell Biology, Advances in experimental medicine and biology, EMBO Reports and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.